Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement D Moher, A Liberati, J Tetzlaff, DG Altman, t PRISMA Group* Annals of internal medicine 151 (4), 264-269, 2009 | 175564* | 2009 |
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement D Moher, A Liberati, J Tetzlaff, DG Altman, t PRISMA Group* Annals of internal medicine 151 (4), 264-269, 2009 | 143852 | 2009 |
Statistical methods for assessing agreement between two methods of clinical measurement JM Bland, DG Altman The lancet 327 (8476), 307-310, 1986 | 57471 | 1986 |
Statistical methods for assessing agreement between two methods of clinical measurements JM Blaud, DG Altman Lancet 12, 307-310, 1986 | 57437 | 1986 |
Measuring inconsistency in meta-analyses JPT Higgins, SG Thompson, JJ Deeks, DG Altman Bmj 327 (7414), 557-560, 2003 | 55590 | 2003 |
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration A Liberati, DG Altman, J Tetzlaff, C Mulrow, PC Gøtzsche, JPA Ioannidis, ... Annals of internal medicine 151 (4), W-65-W-94, 2009 | 52762 | 2009 |
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies E Von Elm, DG Altman, M Egger, SJ Pocock, PC Gøtzsche, ... The lancet 370 (9596), 1453-1457, 2007 | 52500* | 2007 |
The Cochrane Collaboration’s Tool for Assessing Risk of Bias in Randomised Trials JP Higgins The Cochrane Collaboration, 2011 | 30245 | 2011 |
Practical statistics for medical research DG Altman Chapman and Hall/CRC, 1990 | 26128 | 1990 |
Heart disease and stroke statistics—2017 update: a report from the American Heart Association EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ... circulation 135 (10), e146-e603, 2017 | 26013 | 2017 |
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions JAC Sterne, MA Hernán, BC Reeves, J Savović, ND Berkman, ... bmj 355, 2016 | 12766 | 2016 |
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies PF Whiting, AWS Rutjes, ME Westwood, S Mallett, JJ Deeks, JB Reitsma, ... Annals of internal medicine 155 (8), 529-536, 2011 | 12133 | 2011 |
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration JP Vandenbroucke, E Elm, DG Altman, PC Gøtzsche, CD Mulrow, ... Annals of internal medicine 147 (8), W-163-W-194, 2007 | 10793 | 2007 |
Measuring agreement in method comparison studies JM Bland, DG Altman Statistical methods in medical research 8 (2), 135-160, 1999 | 10389 | 1999 |
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials D Moher, KF Schulz, DG Altman The lancet 357 (9263), 1191-1194, 2001 | 10048 | 2001 |
Statistics notes: Cronbach's alpha JM Bland, DG Altman Bmj 314 (7080), 572, 1997 | 8993* | 1997 |
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD) the TRIPOD statement GS Collins, JB Reitsma, DG Altman, KGM Moons Circulation 131 (2), 211-219, 2015 | 8659 | 2015 |
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide TC Hoffmann, PP Glasziou, I Boutron, R Milne, R Perera, D Moher, ... Bmj 348, 2014 | 8127 | 2014 |
Analysing data and undertaking meta‐analyses JJ Deeks, JPT Higgins, DG Altman, Cochrane Statistical Methods Group Cochrane handbook for systematic reviews of interventions, 241-284, 2019 | 7892* | 2019 |
Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research C Kilkenny, WJ Browne, IC Cuthill, M Emerson, DG Altman Journal of Pharmacology and Pharmacotherapeutics 1 (2), 94-99, 2010 | 7777 | 2010 |